Monday, December 14, 2020

Peru halts trial of China Covid vaccine after patient suffers neurological problems

Boxes containing the Pfizer-BioNTech coronavirus vaccine are loaded onto a truck for shipping 

The Peruvian government has suspended its trial of a major Chinese coronavirus vaccine candidate after a participant suffered a serious medical episode, even as the country claims it will begin rolling out jabs in the next three months.  

The Peruvian minister of health Pilar Mazzetti said that the decision of the National Institute of Health (INS) to temporarily stop Sinopharm’s trial in the country was to evaluate the reason behind the adverse incident, which saw a participant experience neurological symptoms.  

German Malaga, chief researcher at the local Cayetano Heredia University, which is involved in the study, said the volunteer had experienced decreased strength in his legs among other symptoms.

The authorities are trying to ascertain if the adverse incident is due to the vaccine or to other reasons. The vaccine was due to complete the first stage of the trials in the next few days.

Read more:

No comments: